| 标题 |
[高分]
1228-OR: First-in-Human Study Demonstrates GIP Receptor (GIPR) Antagonist AT7687 as Well-Tolerated and Suitable for Once-Weekly Subcutaneous Injection for Treatment in People Living with Obesity |
| 网址 | |
| DOI |
10.2337/db26-1228-or
doi
|
| 其它 |
期刊:Diabetes 作者:A. Nejad; J. Boland; A. Hand; K. M. Knudsen; L. Gasbjerg; et al 出版日期:2026-06-07 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)